SCHEMBL552173

SCHEMBL552173

CC(C(=O)O)c1ccc2c(c1)OCCC2=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 5/20 0.64
PTGS1 P23219 4/20 0.64
MAOB P27338 5/20 0.55
MAOA P21397 1/20 0.55
GRM5 P41594 4/20 0.49
FABP4 P15090 1/20 0.45
LTB4R Q15722 1/20 0.44
LTB4R2 Q9NPC1 1/20 0.44
HPGD P15428 2/20 0.44
NPC1 O15118 1/20 0.44
ALDH1A1 P00352 1/20 0.44
NFKB1 P19838 1/20 0.44
RAB9A P51151 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
AKR1C3 P42330 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1761237 0.89 PTGS1 (0.64) PTGS2PTGS1MAOBMAOAGRM5
SCHEMBL8786024 0.85 MAOB (0.51) PTGS2PTGS1MAOBMAOAGRM5
SCHEMBL22967194 0.83 MAOB (0.58) PTGS2PTGS1MAOBMAOAGRM5
SCHEMBL1056332 0.79 PTGS1 (1.00) PTGS2PTGS1LTB4RLTB4R2HPGD
SCHEMBL27581541 0.78 PTGS1 (0.69) PTGS2PTGS1FABP4AKR1C3AKR1C2
SCHEMBL10728119 0.78 PTGS1 (0.44) PTGS2PTGS1MAOBMAOAGRM5
SCHEMBL10594215 0.77 MAOB (0.51) MAOBMAOAGRM5HPGDNPC1
SCHEMBL1813122 0.75 MAOB (0.56) MAOBMAOAGRM5HPGDNPC1
SCHEMBL1533619 0.74 MAOB (0.63) MAOBMAOAGRM5HPGDNPC1
SCHEMBL9734614 0.73 AKR1B1 (0.58) PTGS2PTGS1NPC1ALDH1A1NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120035131-A1 PYRAZOLINE COMPOUNDS PFIZER INC 2012-02-09 US disclosed
US-20100280016-A1 PYRAZOLINE COMPOUNDS PFIZER INC 2010-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035131-A1 PYRAZOLINE COMPOUNDS F12, CYP3A7, ABCG2 PTGS2 2848/4885PTGS1 1963/4885MAOB 134/4885
US-20100280016-A1 PYRAZOLINE COMPOUNDS F12, CYP3A7, ABCG2 PTGS2 2848/4885PTGS1 1963/4885MAOB 134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.